A patient is presented who developed agranulocytosis while taking amodiaquine for suppressive therapy of malaria. An amodiaquine-dependent granulocytotoxic antibody could be demonstrated in the patient's serum on day 1 after stopping amodiaquine medication. Granulocyte transfusion was ineffective on days 6 and 7, possibly due to the slow elimination of the drug.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[amodiaquine-induced agranulocytosis
4
agranulocytosis malaria
4
malaria prevention
4
prevention demonstration
4
demonstration amodiaquine-induced
4
amodiaquine-induced cytotoxic
4
cytotoxic antibody
4
antibody granulocytes]
4
granulocytes] patient
4
patient presented
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!